Search Results 8591-8600 of 36304 for oral
... (oral, implant, ring, patch, IUD) for the duration of the program until at least 30 days after the last DefenCath CLS instillation. (NOTE: The participant ...
oral lobe seizure, Seizure , Absence seizure, Febrile seizure. Show more areas of focus for Anthony L. Fine, M.D.. Sanford M. Fineman ...
Because these small drug-like compounds are not degraded in the gastrointestinal tract, they carry potential as oral agents for the treatment of both Graves' ...
Within four months, her symptoms greatly improved and she was able to tolerate a full oral diet. "It's difficult to conclude that this patient's AGID was ...
... Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer, Thyroid cancer, Melanoma, Squamous cell carcinoma of the skin ...
Congress prize for best oral presentationFifth International Congress on Nutrition and Metabolism in Renal Disease, Strasbourg, France. 1988. First ...
Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...
Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia . J Womens Health (Larchmt) ...
... oral morphine equivalent (OME) after any ophthalmic surgery. Pain management education. The study team provided pain management education to all ophthalmic ...
Treatment was 160 mg of oral zanubrutinib twice daily (n = 50) or 320 mg once daily (n = 23). Efficacy endpoints included overall response rate (ORR) and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!